NASDAQ:KALV - KalVista Pharmaceuticals, Inc.
$25.50
 $0.11
+0.43%
4:00PM EDT
2019-04-18
KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME). The Company is developing a plasma kallikrein inhibitor, which is administered directly into the eye. The Company is engaged in advancing several product candidates developed from its portfolio into early clinical trials. The Company is progressing additional oral candidates towards regulatory preclinical studies. The Company's HAE product candidate, KVD818, is an inhibitor of plasma kallikrein. The Company has initiated clinical testing of KVD818 in a Phase I clinical trial. It has completed an open-label single ascending dose Phase I trial in DME patients with KVD001. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KALV     avg for
industry  
  avg for
sector  
42 stocks weight:  83. 74   203. 85   241. 91  
42 stocks rank:  1. 99 K 1. 44 K 1. 05 K
# analyst opinions:  6. 00   14. 51   13. 97  
mean recommendation:  1. 50   2. 09   2. 01  

quick ratio:  6. 38   5. 27   1. 81  
current ratio:  6. 59   5. 62   2. 25  

target price low:  25. 00   84. 80   115. 21  
target price avg:  32. 00   111. 51   137. 51  
target price high:  35. 00   135. 81   157. 84  
1-yr high:  31. 10   114. 23   138. 78  
last close:  25. 50   87. 66   116. 69  
50-day avg:  24. 89   95. 54   123. 44  
200-day avg:  19. 10   94. 25   121. 11  
1-yr low:  7. 79   72. 78   98. 34  
volume:  43. 63 K 4. 11 M 8. 07 M
50-day avg volume:  151. 84 K 2. 76 M 5. 02 M
200-day avg volume:  92. 79 K 2. 92 M 4. 59 M

1-day return:  0. 43 % -0. 41 % 0. 07 %
this week return:  -2. 56 % -5. 74 % -4. 11 %
12-wk return:  40. 73 % 1. 61 % -0. 05 %
52-wk return:  171. 55 % 3. 12 % 8. 78 %

enterprise value (EV):  328. 77 M 48. 94 B 114. 64 B
market cap:  439. 81 M 43. 07 B 104. 73 B
EBITDA:  -21. 22 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -15. 49   4. 22   12. 73  
enterprise/revenue (EV/R):  18. 22   63. 17   12. 84  
total revenue:  18. 04 M 10. 62 B 38. 47 B
total debt:  109. 00 K 12. 24 B 16. 73 B
debt/equity:  0. 10   46. 71   89. 62  
net income (common):  -12. 95 M 2. 20 B 4. 20 B

shares outstanding:  17. 25 M 571. 70 M 1. 24 B
shares:  9. 17 M 571. 81 M 1. 23 B
shares short:  541. 66 K 10. 17 M 13. 00 M
shares short prior month:  409. 16 K 9. 54 M 17. 33 M
short ratio:  2. 97   5. 41   3. 28  
short % of float:  8. 29 % 5. 45 % 2. 38 %
total cash/share:  6. 44   11. 14   9. 33  
total cash:  111. 15 M 6. 71 B 7. 15 B
free cash flow:  -23. 67 M 3. 58 B 2. 96 B
operating cash flow:  -31. 81 M 4. 15 B 4. 30 B

book value:  6. 03   12. 78   26. 92  
price/book:  4. 23   3. 06   -1. 74  
gross profits:  -9. 84 M 8. 04 B 34. 86 B
operating margins:  -119. 33 % -725. 35 % -89. 04 %
EBITDA margins:  -117. 63 % 10. 94 % 22. 51 %
profit margins:  -71. 76 % 7. 81 % 10. 57 %
gross margins:  -64. 81 % 37. 08 % 55. 70 %

1-yr max volatility:  20. 67 % --- ---
1-yr mean volatility:  0. 52 % 0. 03 % 0. 04 %

1-yr EPS:  -0. 96   2. 40   4. 10  
forward EPS:  -1. 61   3. 97   7. 13  
P/E:  -26. 56   13. 63   22. 72  
forward P/E:  -15. 84   -15. 95   13. 99  
PE/G:  -0. 40   -1. 65   -1. 32  
growth:  66. 90 % 127. 12 % 29. 61 %
earnings high:  -0. 31   1. 00   1. 66  
earnings avg:  -0. 35   0. 77   1. 53  
earnings low:  -0. 42   0. 50   1. 39  
revenue high:  5. 03 M 2. 68 B 10. 78 B
revenue avg:  4. 33 M 2. 59 B 10. 57 B
revenue low:  4. 00 M 2. 49 B 10. 36 B
return on assets:  -13. 93 % -2. 75 % 4. 55 %
return on equity:  -19. 53 % -18. 45 % 5. 46 %
revenue growth:  66. 90 % 92. 86 % 18. 96 %
revenue/share:  1. 34   13. 29   55. 46  

beta (1yr vs S&P500):  0. 97   1. 25   0. 93  
sharpe (1yr):  1. 75   0. 37   0. 70  

held % insiders:  10. 43 % 6. 39 % 3. 38 %
held % institutions:  78. 57 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : KALV
.     + 4.09 =          4.09 :: INITIAL WEIGHT
.   + 94.625 =        98.714 :: inverse volume-to-price addition
.   + 41.874 =       140.588 :: spline projection addition
.    x 3.797 =        533.84 :: 13 weeks' performance factor
.    x 2.766 =      1476.455 :: one-year gains+dividend factor
.    x 1.431 =      2113.432 :: industry recommendation factor
.    x 2.835 =      5991.663 :: symbol recommendation factor
.    x 1.288 =      7719.978 :: EV/R factor
.    x 0.999 =      7709.223 :: return on assets factor
.    x 0.998 =      7694.169 :: return on equity factor
.    x 2.521 =      19393.16 :: revenue growth factor
.    x 2.828 =      54849.41 :: current ratio factor
.    x 1.089 =     59729.814 :: quick ratio factor
.    x 1.156 =     69057.076 :: short ratio factor
.    x 2.042 =    141033.509 :: price-to-book factor
.    x 1.001 =    141191.919 :: debt-to-equity factor
.    x 1.332 =    188111.968 :: 5-day avg > 200-day avg
.    x 1.022 =    192328.506 :: 5-day avg > 50-day avg
.    x 1.303 =    250624.205 :: 50-day avg > 200-day avg
.    x 1.021 =    255833.181 :: P/E weight
.     x 1.26 =    322289.506 :: PE/G factor
.    x 1.636 =    527133.483 :: beta factor
.    x 1.746 =    920201.952 :: sharpe factor
.    x 0.986 =    907316.547 :: target low factor
.    x 1.168 =   1060011.318 :: target mean factor
.    x 1.061 =    1124711.01 :: target high factor
.     x 1.31 =   1473245.342 :: industry 2-weeks return factor
.    x 0.907 =   1336953.512 :: "drift" penalty 2 days ago
.      x 1.0 =    1336638.69 :: overall "drift" factor
.    x 0.793 =   1060400.079 :: largest single-day jump factor
.     x 1.01 =   1070948.927 :: mean volatility factor
.    x 1.096 =   1173799.289 :: 42-day mean volatility factor
.      x 1.0 =   1173608.754 :: factor hist industry gain for week 16
.   cubeRoot =       105.481 :: reduced to standardize
.   - 21.742 =        83.739 :: add/subtract for performance
.                     83.739 :: FINAL WEIGHT for NASDAQ:KALV


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org